Microbial detection methods are inherently flawed by three key factors, here we summarise Tim Sandle’s explanation of the concerns surrounding microbial methods and sampling.
A recently published paper suggests the test panel of micro-organisms needs to be reviewed and likely expanded to ensure it is suitable for application in the pharma industry.